Trading Signals: TGTX Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 14, 2022)(TG Therapeutics Inc)
| TGTX latest price $20.8000 (0.14%) ($20.2400 - $21.2000) on Thu. Aug. 6, 2020. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 4.04% (three month average) | RSI | 34 | Latest Price | $20.8000(0.14%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | TGTX advances 0.8% a day on average for past five trading days. | Weekly Trend | TGTX declines -4.2% a week on average for past two weeks. | Market Behavior | Growth stock rally for large cap. Normal for small cap. | Correlated ETFs | Broad market will support TGTX advance at 0% a week (0% probability) XBI(63%) ARKG(59%) ARKK(56%) IWO(56%) IBB(55%) | Factors Impacting TGTX price | TGTX will decline at least -2.02% in a week (0% probabilities). VIXM(-34%) VXX(-32%) UUP(-18%) DRIV(-5%) XLC(-3%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -2.02% (StdDev 4.04%) | Hourly BBV | 0 () | Intraday Trend | -0.3% | | | |
|
Resistance Level | $21.42 | 5 Day Moving Average | $20.47(1.61%) | 10 Day Moving Average | $20.45(1.71%) | 20 Day Moving Average | $21.42(-2.89%) | To recent high | -13.9% | To recent low | 23.8% | Market Cap | $2.634b | | | | TG Therapeutics, Inc. is a biopharmaceutical company, which engages in the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its product pipeline includes TG-1101, Ublituximab, and Umbralisib. The company was founded by Michael Sean Weiss and Laurence H. Shaw on May 18, 1993 and is headquartered in New York, NY. |